OxTalks is Changing
On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Designing a Synthetic Killer based on a Natural Template
Prof. Karl-Johan Malmberg (M.D. Ph.D) is a Specialist in Hematology with over 25 years of experience in NK cell research and cancer immunotherapy. He is the Director of a Norwegian Research Council Center of Excellence, The Precision Immunotherapy Alliance (PRIMA) and leads an international team of 20 scientists based in laboratories both at the University of Oslo, Norway and the Karolinska Institutet, Sweden. He is also the Scientific Director of the Center for Advanced Cell and Gene Therapy (ACT) at Oslo University Hospital. The group focus on deciphering basic cellular and molecular mechanisms regulating NK cell function and seek to translate insights from these efforts in the design of novel approaches for NK-cell based cancer immunotherapy against cancer.
Date:
9 January 2025, 13:00
Venue:
Seminar Room, NDM Research Building, Old Road Campus, Headington, OX3 7FZ
Speaker:
Professor Karl-Johan Malmberg (Director, The Precision Immunotherapy Alliance (PRIMA), The University of Oslo)
Organising department:
Nuffield Department of Clinical Medicine
Organiser:
Karen Poxon (University of Oxford)
Part of:
CIO Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Karen Poxon
